Leidos's Q2 2026 revenue was $4.55B (+7.4% year over year). Net income was $354.0M.
Guidance: Revenues: $18.20B - $18.40B (prior guidance: $18.00B - $18.40B); Adjusted EBITDA Margin: Mid 13%; Non-GAAP Diluted EPS: $12.20 - $12.50 (prior guidance: $12.10 - $12.50)
Insights & Commentary
"MHS Genesis success opens new business opportunities." — Leidos Q2 FY26 Earnings Presentation
"Strength and resilience of NorthStar 2030 Strategy on full display in strong 2Q results and enhanced 2026 guidance." — Leidos Q2 FY26 Earnings Presentation
"Intelligence & Digital segment revenues were $1,499 million for Q2 FY26, up 6.5% compared to $1,408 million in Q2 FY25." — Leidos Q2 FY26 Earnings Presentation
"Intelligence & Digital segment Non-GAAP Operating Income margin was 10.1% in Q2 FY26, flat compared to 10.1% in Q2 FY25." — Leidos Q2 FY26 Earnings Presentation
"Health segment revenues were $1,086 million for Q2 FY26, down 7.6% compared to $1,175 million in Q2 FY25." — Leidos Q2 FY26 Earnings Presentation
"Health segment Non-GAAP Operating Income margin was 23.8% in Q2 FY26, down 250 basis points compared to 26.3% in Q2 FY25." — Leidos Q2 FY26 Earnings Presentation
Figures from SEC EDGAR filings for the period ended 2026-07-03. Commentary from public earnings-call transcripts and coverage.